Medication

GLP-1 (Glucagon-Like Peptide-1)

GLP-1 is a hormone whose receptor agonists (semaglutide, tirzepatide) are FDA-approved for weight loss and glycemic control.

GLP-1 is an incretin hormone released by the gut. GLP-1 receptor agonists — including semaglutide and dual-agonists like tirzepatide — slow gastric emptying, reduce appetite, and improve glycemic control. REVRCEL prescribes compounded GLP-1 medications under physician oversight, with quarterly bloodwork to track HbA1c, ApoB, fasting insulin, and metabolic markers.

Related terms

Semaglutide Tirzepatide

Statements have not been evaluated by the FDA. Educational content only; not medical advice.